Archive Newsletter
-
06.03.26 -- Will FDA's One-Day Inspection Pilot Stand The Test Of Time?
6/3/2026
06/03/26 Cell & Gene Newsletter
-
06.02.26 -- STREAM Edition: Redefining CAR-T Timing And Patient Access With Allogene Therapeutics' Dr. Zachary Roberts
6/2/2026
06/02/26 Cell & Gene Newsletter
-
06.02.26 -- Why the Right Manufacturing Partner Is About More Than Capacity
6/2/2026
06/02/26 Cell & Gene Newsletter
-
06.01.26 -- Cut Variability, Raise Titers, And Scale With Confidence
6/1/2026
06/01/26 Cell & Gene Newsletter
-
06.01.26 -- CGT Manufacturing Shifts From Capacity To Strategy
6/1/2026
06/01/26 Cell & Gene Newsletter
-
05.29.26 -- Securing Your Advanced Therapy Pipeline
5/29/2026
05/29/26 Cell & Gene Newsletter
-
05.29.26 -- Materials Matter: Reframing Raw Material Strategy In Cell And Gene Therapy Development
5/29/2026
05/29/26
-
05.28.26 -- Accelerate Your Assay And Imaging Data With These New Tools
5/28/2026
05/28/26 Cell & Gene Newsletter
-
05.28.26 -- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
5/28/2026
05/28/26 Cell & Gene Newsletter
-
05.27.26 -- Smarter Processing For Workflows From Discovery To Commercial Scale
5/27/2026
05/27/26 Cell & Gene Newsletter